ScandiDos AB (publ) (SDOS.ST)
Uppsala, AB, SE
ScandiDos AB (publ), together with its subsidiaries, provides measurement phantoms and software solutions for the quality assurance and validation of dynamic and modulated treatments adopted in clinics in the United States, Europe, Asia, and internationally. The company offers Delta4 products comprising Delta4 Phantom+, Delta4Phantom+MR, Delta4 HexaMotion, Delta4Insight, Delta4DVH Anatomy, Delta4 Machine QA, and Delta4 Statistics Module for the quality assurance in advanced radiation therapy techniques, such as VMAT, RapidArc, IMRT, and Tomotherapy. It sells its products directly to consumers and through distributors. ScandiDos AB (publ) was founded in 2001 and is headquartered in Uppsala, Sweden.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.60% | +1.20% | -20.00% | -9.09% | -28.81% | -26.96% | -40.43% | -67.69% | -78.95% | -81.99% | -93.92% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Software - Application: +13.0%-10.3% Q2'26: -7.5% (vs Q2'25)
-
EPS growth Software - Application: +28.6%+81.2% ★ Q2'26: +120.4% (vs Q2'25)
-
FCF margin FCF growth · Software - Application: +45.3%-4.5% Q2'26: +0.0% (vs Q2'25)
-
EBIT margin Software - Application: +9.4%-5.0% Q2'26: -1.2% (vs Q2'25)
-
ROIC Software - Application: +7.5%-7.3% Q2'26: -1.9% (vs Q2'25)
-
Share dilution Software - Application: +0.0%+25.0% Q2'26: +0.0% (vs Q2'25)
-
Debt / EBITDA Net debt/EBITDA · Software - Application: -1.16×0.00× Q2'26: 0.00× (vs Q2'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Apr 2015 actual |
Apr 2016 actual |
Apr 2017 actual |
Apr 2018 actual |
Apr 2019 actual |
Apr 2020 actual |
Apr 2021 actual |
Apr 2022 actual |
Apr 2023 actual |
Apr 2024 actual |
Apr 2025 actual |
Apr 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
32.92M
est: 29.22M (+12.7%)
|
33.58M
est: 36.00M (-6.7%)
|
47.41M
est: 59.00M (-19.6%)
|
50.57M
est: 51.00M (-0.8%)
|
48.82M
est: 59.49M (-17.9%)
|
57.27M
est: 69.92M (-18.1%)
|
59.99M
est: 61.00M (-1.7%)
|
57.68M
est: 57.00M (+1.2%)
|
61.55M
est: 62.95M (-2.2%)
|
60.43M
est: 71.00M (-14.9%)
|
60.43M
est: 79.00M (-23.5%)
|
87.00M
87.00M – 87.00M
+10.1% YoY
|
| EBITDA |
-14.22M
est: -3.51M (-305.2%)
|
-12.36M
est: -4.32M (-185.9%)
|
-8.00M
est: -7.09M (-12.9%)
|
-6.58M
est: -6.13M (-7.4%)
|
-16.93M
est: -7.15M (-137.0%)
|
-12.73M
est: -8.40M (-51.5%)
|
-1.58M
est: -7.33M (+78.5%)
|
-7.11M
est: -6.85M (-3.8%)
|
-8.26M
est: -7.56M (-9.2%)
|
-13.36M
est: -8.53M (-56.6%)
|
-5.79M
est: -9.20M (+37.1%)
|
-10.13M
-10.13M – -10.13M
-10.1% YoY
|
| EBIT |
-14.49M
est: -4.27M (-239.2%)
|
-13.49M
est: -5.26M (-156.3%)
|
-12.58M
est: -8.63M (-45.8%)
|
-11.08M
est: -7.46M (-48.6%)
|
-16.97M
est: -8.70M (-95.1%)
|
-12.76M
est: -10.22M (-24.8%)
|
-1.62M
est: -8.92M (+81.8%)
|
-7.17M
est: -8.33M (+13.9%)
|
-8.33M
est: -9.20M (+9.5%)
|
-13.42M
est: -10.38M (-29.3%)
|
-13.42M
est: -11.91M (-12.7%)
|
-13.12M
-13.12M – -13.12M
-10.1% YoY
|
| Net Income |
-14.68M
est: -56.93M (+74.2%)
|
-14.24M
est: -31.81M (+55.2%)
|
-13.16M
est: -12.22M (-7.7%)
|
-11.57M
est: -39.28M (+70.6%)
|
-17.76M
est: -16.85M (-5.4%)
|
-13.13M
est: 2.00M (-756.9%)
|
-1.40M
est: -2.28M (+38.7%)
|
-7.34M
est: -9.12M (+19.6%)
|
-9.12M
est: -9.12M (+0.0%)
|
-14.65M
est: -912.2K (-1,505.7%)
|
-14.65M
est: 10.26M (-242.7%)
|
11.40M
11.40M – 11.40M
+11.1% YoY
|
| SGA |
15.82M
est: 8.36M (+89.2%)
|
13.61M
est: 10.30M (+32.1%)
|
18.66M
est: 16.88M (+10.5%)
|
19.98M
est: 14.59M (+36.9%)
|
22.81M
est: 17.02M (+34.0%)
|
21.55M
est: 20.01M (+7.7%)
|
14.37M
est: 17.46M (-17.7%)
|
16.17M
est: 16.31M (-0.9%)
|
56.08M
est: 18.01M (+211.3%)
|
53.40M
est: 20.32M (+162.8%)
|
43.55M
est: 44.17M (-1.4%)
|
48.64M
48.64M – 48.64M
+10.1% YoY
|
| EPS |
-1.11
est: -1.25 (+11.1%)
|
-0.76
est: -0.70 (-9.0%)
|
-0.50
est: -0.27 (-86.6%)
|
-0.40
est: -0.86 (+53.6%)
|
-0.61
est: -0.37 (-65.1%)
|
-0.32
est: 0.04 (-830.0%)
|
-0.03
est: -0.05 (+32.6%)
|
-0.18
est: -0.20 (+10.0%)
|
-0.20
est: -0.20 (+0.0%)
|
-0.32
est: -0.02 (-1,500.0%)
|
-0.32
est: 0.18 (-277.8%)
|
0.20
0.20 – 0.20
+11.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-18 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-06-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-06-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-06-15 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-06-12 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-06-11 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-06-10 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-06-09 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-06-05 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-06-04 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-06-03 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-06-02 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-06-01 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-28 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-26 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-25 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-19 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-18 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-15 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-13 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-12 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Carl Gustaf Piehl | MD & Chief Executive Officer | 2M | male |
| Anders Murman | Acting Chief Executive Officer | — | male |
| Daniel Pederson | Chief Technology Officer & Quality Manager | — | male |
| Henriette Munch | Chief Financial Officer | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SDOS.ST
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
